Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"October 13, 2026 3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . “
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Individuals who were physically active had a 16% lower risk for all-cause mortality than those who were inactive. Baseline fibrosis did not affect the association between physical activity and mortality. NASHVILLE, Tenn. \u2014 Individuals with steatotic liver disease who engaged in leisure-time physical activity had a 16% lower risk for all-cause mortality, regardless of fibrosis status, according to a presenter. Data presented at ACG Annual Scientific Meeting also showed that the greatest reduction in mortality was observed when individuals moved from a sedentary lifestyle to even modest levels of physical activity.
Sanhiljot Singh Bhupal, MD, MSHIST, speaks at the podium during ACG Annual Scientific Meeting.\u00a0Photo: Heather Biele.
\u201cIt is already established that cardiovascular disease remains a major cause of death in these patients, and we do see poor cardiovascular status,\u201d Sanhiljot Singh Bhupal, MD, MSHIST, a second-year internal medicine resident at St. Francis Medical Center in Lynwood, California, told Healio. \u201cWe already know that exercise is one of the foundations of treatment. It can improve hepatic steatosis and cardiometabolic health even without significant weight loss. \u201cBut we felt there were still some important unanswered questions about why physical activity is associated with better long-term outcomes,\u201d he added. Bhupal and colleagues analyzed data from the 1988-1994 National Health and Nutrition Examination Survey and National Death Index through 2019 to evaluate the dose-response relationship between physical activity and all-cause mortality among individuals with steatotic liver disease. The researchers classified participants as \u201cphysically active\u201d if they reported any leisure time activity (>0 MET-minutes per week) and \u201cinactive\u201d if they reported none (0 MET-minutes), using self-reported data from NHANES interviews. They also estimated liver fibrosis via FIB-4 index values and stratified participants as low, intermediate or high risk. Final analysis included 4,441 adults aged 20 to 74 years, representing 46.3 million adults. Most (85.5%) had metabolic dysfunction-associated liver disease, 12.2% had metabolic dysfunction and alcohol-associated liver disease, and 2.3% had alcohol-associated liver disease. Over median follow-up of 26 years, 1,903 deaths occurred. Mortality was significantly lower among individuals who were physically active vs. inactive (36.4% vs. 44%; P = .008). Those who were physically active were more likely to be men (55% vs. 34.9%), had attained at least a college education (19.8% vs. 6.4%) and had a higher income-to-poverty ratio (3.27 vs. 2.35). The link between physical activity and lower all-cause mortality was significant only for MASLD. Analysis adjusted for demographic, socioeconomic and clinical factors showed physical activity was associated with a 16% lower risk for all-cause mortality (adjusted HR = 0.84; 95% CI, 0.71-0.99). This risk remained the same after including FIB-4 values. \u201cThe hazard ratio essentially did not change,\u201d Bhupal told Healio. \u201cAlthough fibrosis itself remained an important predictor of mortality, it did not appear to explain most of the survival benefit associated with physical activity. That suggests much of the benefit may be coming through extrahepatic pathways, particularly cardiometabolic health.\u201d The researchers also found that the protective association between physical activity and mortality appeared strongest during the first 10 years of follow-up (aHR = 0.68; 95% CI, 0.49-0.94). However, physical activity was measured only at baseline, Bhupal noted. \u201cOver 20 or 30 years, people\u2019s activity levels can change substantially,\u201d he said. \u201cThe further we get from that original measurement, the less accurately it represents what that person is actually doing. Clinically, I think that reinforces the idea that physical activity is something we need to reassess and encourage over time, rather than discuss once.\u201d Dose-response analysis also showed a significant nonlinear relationship, with the greatest reduction in mortality occurring when individuals went from being completely inactive to incorporating even modest physical activity. \u201cWe should be talking about physical activity with essentially every patient with steatotic liver disease, and especially with patients who are completely sedentary,\u201d Bhupal told Healio. \u201cWe should still encourage patients to work toward guideline-recommended levels of activity, but if somebody is doing no physical activity at all, getting them to start walking or doing another activity they can realistically maintain may already be an important step. Bhupal emphasized that these results highlight the importance of holistic care for patients with steatotic liver disease, rather than solely focusing on progression of liver disease. \u201cPhysical activity matters in steatotic liver disease, and its benefits appear to go well beyond the liver,\u201d he said. For more information: Sanhiljot Singh Bhupal, MD, MSHIST, can be reached at gastroenterology@healio.com . Published by: Sources\/Disclosures Source: Bhupal SS, et al. Relationship between leisure-time physical activity and mortality in SLD: A 31-year population-based study. Presented at: ACG Annual Scientific Meeting; Oct. 12-14, 2026; Nashville, Tenn. (hybrid meeting).
Disclosures:
Bhupal reports no relevant financial disclosures. Please see the study for all other authors\u2019 relevant financial disclosures.
Ask a clinical question and tap into Healio AI’s knowledge base.
PubMed, enrolling\/recruiting trials, guidelines
Clinical Guidance, Healio CME, FDA news
Healio’s exclusive daily news coverage of clinical data
Learn more
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . “
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Source link<\/p>\n","protected":false},"author":1,"featured_media":4006,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/4005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4005"}],"version-history":[{"count":0,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/posts\/4005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=\/wp\/v2\/media\/4006"}],"wp:attachment":[{"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drsoniafawad.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Healio](\"https:\/\/www.healio.com\/~\/media\/h5\/feature\/news\/publogos\/hgld\/healio_gastro.svg?la=en&h=40&w=152&hash=2C654A538F2E250F5183D42A89FE0EC0\")
\n <\/div>\n<\/p><\/div>\n<\/p><\/div>\n